Live Webinar

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Hosted by AJMC and Targeted Oncology

-- Days : -- HRS : -- MIN : -- SEC
Register Now →
Logo Image
|Articles|September 1, 1996

The American Journal of Managed Care

  • September 1996
  • Volume 2
  • Issue 8

Pharmacoeconomic Evaluation of HMG-CoA Reductase Inhibitors in the Treatment of Hypercholestrolemia

Download PDF: Pharmacoeconomic Evaluation of HMG-CoA Reductase Inhibitors in the Treatment of Hypercholestrolemia

Articles in this issue

almost 30 years ago

Determinants of Hospital Charges and Costs in Acute Myocardial Infarction: A Report from the Myocardial Infarction Cost Study (MICS) Group

almost 30 years ago

The Effectiveness of Postgraduate Education on the Clinical Breast Examination Skills of Primary Care Physicians

almost 30 years ago

Treatment Outcome in an Outpatient Asthma Center: Retrospective Questionnaire Data

almost 30 years ago

Potential Cost-Effectiveness of Acute Stroke Treatment

almost 30 years ago

Effect of a Comprehensive Nurse-Managed Diabetes Program: An HMO Prospective Study

almost 30 years ago

The Economic Organization of Health Resource Allocation: Decision Making in the New Environment

almost 30 years ago

Potential for SSRIs as Monotherapy for Comorbid Psychiatric Disorders

almost 30 years ago

Establishing the Basis for Successful Disease Management Contracting

almost 30 years ago

Accreditation Standards in Managed Care

almost 30 years ago

A Closer Look at Capitation

Related Content